Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Completed · Phase 4

Conditions studied: Skin Aging

In brief

This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

Key facts

Study ID

NCT00856414

Run by

Allergan

People needed

45

Starts

2009-03-01

Expected to finish

2009-04-01

Last updated by the study team

2019-01-29

Who can join

Age: 35 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female subjects of any race, 35-55 years of age
• Moderate to severe glabellar wrinkles (lines between the eyebrows)

You may not qualify if…

• Previous botulinum toxin therapy
• Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control
• Subjects planning a facial cosmetic procedure or visible scars
• Previous cosmetic surgery to the upper face
• Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function
• History of facial nerve palsy
• Allergy or sensitivity to any component of the study medication

Where it is running

• Study site — West Palm Beach, Florida, United States
• Study site — Livonia, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.